相关实验视频
Updated: Jun 28, 2025

06:53
Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
12.4K
在先进的基底细胞癌中对Sonidegib的临床反应的临床决定因素:一个单中心体验
G Spallone1, A Carbone, F Sperati
1Oncologic and Preventive Dermatology Unit, San Gallicano Dermatological Institute, IRCCS, Rome, Italy. giuliaspallone@hotmail.it.
European review for medical and pharmacological sciences
|April 19, 2024
概括
这项研究没有发现患者特征与Sonidegib对局部先进的基底细胞癌的完整反应之间的显著联系. 治疗修改是常见的,但在现实环境中与更好的结果无关.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
背景情况:
- 局部发达的基础细胞癌 (laBCC) 是一个具有挑战性的诊断.
- 刺途径抑制剂,如Sonidegib,已被批准用于laBCC的治疗方法.
- 关于治疗有效性和反应决定因素的现实数据至关重要.
研究的目的:
- 评估用Sonidegib治疗的laBCC患者的完整反应的临床决定因素.
- 在现实生活环境中分析反应率和与治疗相关的不良事件.
主要方法:
- 成年laBCC患者接受索尼迪吉布治疗的回顾性观察研究.
- 收集关于患者,瘤和治疗特征的数据.
- 完全响应率是主要结果;响应时间和不良事件是次要的.
主要成果:
- 在19名患者中,42.1%的患者实现了完全响应,36.8%的患者获得了部分响应,21%的患者获得了疾病进展.
- 最佳反应的中位时间为部分反应3个月,完全反应3.5个月.
- 与治疗相关的不良事件发生在73.6%的患者中,78.9%的患者需要修改治疗计划.
结论:
- 在临床结果和临床病理学或治疗特征之间没有观察到统计学意义上的关联.
- 该研究证实,临床反应与Sonidegib的替代剂量方案之间没有显著的相关性.
更多相关视频
相关概念视频
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K

